April 25th 2025
Expanding Medicare coverage for glucagon-like peptide 1 (GLP-1) receptor agonists could significantly reduce obesity-related health issues, but it also risks adding tens of billions in new costs, highlighting the need for smart policy strategies to ensure access, affordability, and long-term sustainability.
Study Finds ACOs Have No Meaningful Impact on Medication Use or Adherence
July 25th 2017Many accountable care organizations participating in the Medicare Shared Savings Program focus on disease control and medication use, but a new study published in JAMA Cardiology has found that the programs have not made any meaningful changes in medication use or adherence.
Read More
Dr Sachin Jain Discusses CareMore's Community Partnerships, Internal Programs
July 18th 2017CareMore is beginning to form innovative partnerships with companies like Lyft, while also strengthening its internal ability to provide more outreach, according to Sachin H. Jain, MD, MBA, president and CEO. Jain said that CareMore’s prepaid model allows it to fully manage every dollar it receives.
Watch
Rule Would Limit Digital Providers to Makeup Sessions When Medicare Launches DPP in 2018
July 14th 2017Digital providers have been seen as crucial to scaling the Diabetes Prevention Program to the 22 million seniors with prediabetes. Medicare spends $1 out of every $3 on diabetes, and disease prevention is essential to lowering overall healthcare spending.
Read More
Dr Sachin Jain on CareMore's Mission to Manage Chronic Disease From the Dentist's Chair
July 8th 2017CareMore has launched an integrated delivery model that provides primary care to patients while at the dentist’s office, with the idea of maximizing the value of each encounter with the healthcare system, explained Sachin H. Jain, MD, MBA, president and CEO.
Watch
Nina Brown-Ashford: DPP Will Improve Care and Costs for Prediabetes Patients
July 6th 2017Nina Brown-Ashford, MPH, CHES, deputy group director at the CMS Innovation Center, discusses how Medicare’s Diabetes Prevention Program will help improve population health and contain the high costs of diabetes care.
Watch
Medicare Inpatient and Postdischarge Outcomes of Elective Percutaneous Coronary Interventions
An understanding of risk-adjusted outcomes for percutaneous coronary interventions for both inpatient and 90-day postdischarge events is necessary for the redesign of care outcomes.
Read More
CMS Proposes Amending MACRA Rules to Alleviate Physician Burden, Exempt More Practices in 2018
June 21st 2017In response to trepidation from clinicians, CMS has announced a proposal to alter the rules of the Quality Payment Program established by the Medicare Access and CHIP Reauthorization Act (MACRA). The changes will exempt thousands of physicians from quality reporting requirements and allow small practices to form “virtual groups” with one another.
Read More
CGM "Debate" Finds Benefits, Barriers to Uptake for Type 2 Diabetes
June 12th 2017A light-hearted format for the discussion at the 77th Scientific Sessions of the American Diabetes Association still brought out the seriousness of the issue: too many with type 2 diabetes have poor glycemic control, and another medication may not be the answer.
Read More
Nina Brown-Ashford Outlines Development and Next Steps of CMS Diabetes Prevention Program
June 11th 2017The Diabetes Prevention Program (DPP) has demonstrated that it can improve the quality of care for Medicare beneficiaries with diabetes while saving or maintaining costs, explained Nina Brown-Ashford, MPH, CHES, deputy group director at the CMS Innovation Center. Next, CMS will finalize the DPP’s expansion in another round of rulemaking.
Watch
Medicare's Diabetes Prevention Program Is Coming, but CMMI Has Work to Do
June 11th 2017No one questions the long-term savings that the Diabetes Prevention Program will bring to Medicare, but getting it off the ground will require several steps that have never been done before, including a new payment model.
Read More
Poor COPD Medication Adherence Observed in Older Patients With Comorbid Depression
June 8th 2017Patients with comorbid depression and chronic obstructive pulmonary disease (COPD) have low rates of adherence to their COPD management medications, putting them at increased risk of emergency department visits and hospitalizations.
Read More